Belen Arranz Martí
Investigador
Belén Arranz Martí is licensed in Medicine by the Autonomous University of Barcelona. He is a specialist in Clinical Biochemistry and Specialist in Psychiatry and doctor in Medicine and Surgery from the University of Linköping, Sweden.
She undertook a predoctoral stay at the Department of Psychiatry of the University of Linköping and the University of Gothenburg (Sweden) during the years 1992 and 1994, for the study of biomarkers in post-mortem brain.
Since 2017 she is coordinator of the CSMA of Cornellà, Parc Sanitari Sant Joan de Déu.
Member of CIBERSAM, group G11.
Professional network profiles
Last Publications
- Farrés J, Ruiz JL, Mas JM, Arias L, Sarrias MR, Armengol C, Cardona PJ, Munoz-Moreno JA, Vilaplana M, Arranz B, Usall J, Serrano-Blanco A and Vilaplana C Identification of the most vulnerable populations in the psychosocial sphere: a cross-sectional study conducted in Catalonia during the strict lockdown imposed against the COVID-19 pandemic. BMJ Open . 11(11): .
- Calderon-Mediavilla M, Vila-Badia R, Dolz M, Butjosa Molines A, Barajas A, del Cacho N, Sánchez Fernández B, Pardo M, Baños I, Usall J, Ochoa S, GENIPE Group and PROFEP Group Depressive symptoms and their relationship with negative and other psychotic symptoms in early onset psychosis. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY . 30(9): 1383-1390.
- Huerta-Ramos ME, Labad J, Cobo JV, Nuñez C, Creus M, García-Parés G, Cuadras-Palleja D, Franco J, Miquel E, Reyes JC, Marcó-García S, RALOPSYCAT Group and Usall J Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial European archives of psychiatry and clinical neuroscience . 270(6): 729-737.
Projects
- Project name:
- Contratos para la Intensificación de la actividad investigadora en el SNS
- Leader
- Belen Arranz Martí
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- INT19/00014
- Starting - finishing date:
- 2020 - 2020
- Project name:
- La permeabilidad intestinal como causa de inflamación crónica de bajo grado en pacientes con esquizofrenia: relación con la dieta, el síndrome metabólico y la gravedad de la enfermedad
- Leader
- Belen Arranz Martí
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PI17/00246
- Starting - finishing date:
- 2018 - 2022
News
-
Research identifies six groups in the population more susceptible to the impact of the pandemic
Dr. Belén Arranz, Dr. Judith Usall i Rodié and Dr. Antoni Serrano from the Institut de Recerca Sant Joan de Déu participate in the project COM-COVID, leds by Dr. Cristina Vilaplana from the Germans Trias i Pujol Research Institute.